NCT06690086View on ClinicalTrials.gov

DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

CompletedOBSERVATIONAL
Enrollment

1,028

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

December 9, 2021

Study Completion Date

December 9, 2021

Conditions
Skin Cancer
Interventions
PROCEDURE

Lesion biopsy

Lesions enrolled in the study are biopsied to confirm histopathology

DEVICE

DermaSensor Device Use

Users are blinded to the DermaSensor Device result

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

DermaSensor, Inc.

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

DermaSensor, Inc.

INDUSTRY

NCT06690086 - DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer | Biotech Hunter | Biotech Hunter